HEPATIC ADENOMATOSIS IN A 32-YEAR-OLD MALE WITH NO RISK FACTORS FOR HEPATIC ADENOMA
AbstractHepatic Adenomatosis most commonly arises in the background of hepatic adenoma in young women and less commonly in men with underlying risk factors. Rarely, it can arise in young men with none of the associated risk factors and thus can go undetected for a prolonged period resulting in delayed intervention and avoidable complications. We present a rare case of a 32-year-old asymptomatic male that presented for routine evaluation and was subsequently diagnosed with Hepatic Adenomatosis.
Martinez-Mier G, Enriquez De los Santos H, Grube-Pagola P. Large hepatic adenoma in a 21-year-old male. BMJ Case Rep 2013;2013:bcr2013202111.
Socas L, Zumbado M, Pérez LO, Ramos A, Pérez C, Hernández JR, et al. Hepatocellularadenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med 2005;39(5):e27.
Howell RR, Stevenson RE, Ben-Menachem Y, Phyliky RL, Berry DH. Hepatic adenomata with type 1 glycogen storage disease. JAMA 1976;236(13):1481–4.
Haring MPD, Vriesendorp TM, Klein Wassink-Ruiter JS, de Haas RJ, Gouw ASH, de Meijer VE. Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers. Liver Int 2019;39(11):2042–45.
Larson BK, Guindi M. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice. Am J Clin Pathol 2017;147(6):557–70.
Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F, et al. Liver adenomatosis: an entity distinct from liver adenoma. Gastroenterology 1985;89(5):1132–8.
Védie AL, Sutter O, Ziol M, Nault JC. Molecular classification of hepatocellular adenomas: impact on clinical practice. Hepat Oncol 2018;5(1):HEP04.
Toso C, Majno P, Andres A, Rubbia BL, Berney T, Buhler L, et al. Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors. World J Gastroenterol 2005;11(36):5691–5.